Karyopharm announces xpovio® (selinexor) data to be presented at the 2021 american society of clinical oncology annual meeting

Newton, mass., may 19, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that sixteen abstracts have been selected for virtual presentation, including one oral presentation, at the upcoming 2021 american society of clinical oncology (asco) annual meeting taking place june 4-8, 2021.
KPTI Ratings Summary
KPTI Quant Ranking